National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 60219-60220 [2023-18836]

Download as PDF Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Notices 60219 TABLE 1—RECIPIENTS AND AWARD AMOUNTS Grant No. Award recipient name City, state Award amount UF5MC32750 .......................... National Institute for Children’s Health Quality ........................ Boston, MA ............................. $1,900,000 Justification: HRSA will provide supplemental award funds to the current SHSPP recipient in fiscal year 2023 to provide new and continued support to Healthy Start grant recipients. The current recipient of the SHSPP is best positioned to address the objectives that to be supported by the supplemental funds, including supporting data collection and evaluation and implementing applicable Executive Orders. DEPARTMENT OF HEALTH AND HUMAN SERVICES Carole Johnson, Administrator. ACTION: [FR Doc. 2023–18798 Filed 8–30–23; 8:45 am] SUMMARY: Health Resources and Services Administration HRSA-Initiated Supplemental Funding to the Supporting Maternal Health Innovation Program Health Resources and Services Administration (HRSA), Department of Health and Human Services. AGENCY: Notice of supplemental award. HRSA is providing supplemental funds not to exceed $1,500,000 to the Supporting Maternal Health Innovation Program, also referred to as the Maternal Health Learning and Innovation Center (MHLIC), in fiscal year (FY) 2023 to provide support and capacity building to HRSA’s new maternal health award recipients under the State Maternal BILLING CODE 4165–15–P Health Innovation (MHI) Program (HRSA–23–108). FOR FURTHER INFORMATION CONTACT: Kimberly Sherman, Chief, Maternal and Women’s Health Branch, Division of Healthy Start and Perinatal Services, Maternal and Child Health Bureau, HRSA, at ksherman@hrsa.gov or (301) 443–1702. SUPPLEMENTARY INFORMATION: Intended Recipient of the Award: One award to the University of North Carolina at Chapel Hill, the current recipient under the Supporting Maternal Health Innovation Program, now known as MHLIC, as listed in Table 1. Amount of Non-Competitive Award: Up to $1,500,000. Project Period: September 30, 2019, to September 29, 2024. CFDA Number: 93.110. Award Instrument: Supplement. Authority: 42 U.S.C. 701(a)(2) (title V, section 501(a)(2) of the Social Security Act). ddrumheller on DSK120RN23PROD with NOTICES1 TABLE 1—SUPPORTING MHI PROGRAM AWARD RECIPIENT (2019–2024) Grant No. Grantee organization City, state Award amount U7CMC33636 University of North Carolina at Chapel Hill ..................................................................................... Raleigh, NC ... $1,500,000 Justification: The Consolidated Appropriations Act, 2023 (Pub. L. 117– 328) included additional Special Projects of Regional and National Significance funding. The Explanatory Statement accompanying the Consolidated Appropriations Act specified a $26 million increase for the State MHI Program to establish new cooperative agreements in FY 2023 with up to 23 new states. MHLIC provides support and capacity building to HRSA’s maternal health award recipients. Supplemental funds to MHLIC will be used to provide support and capacity building to the new cohort of FY 2023 State MHI award recipients. The requested activities are within scope of the Supporting Maternal Health Innovation Program. Carole Johnson, Administrator. [FR Doc. 2023–18799 Filed 8–30–23; 8:45 am] BILLING CODE 4165–15–P VerDate Sep<11>2014 18:04 Aug 30, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK SEP High Risk Multi-Center Clinical Study Cooperative Agreement U01. Date: September 28, 2023. Time: 12:00 p.m. to 1:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review Officer, NIDDK/ Scientific Review Branch, National Institutes of Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301–402–6711, cheryl.nordstrom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) E:\FR\FM\31AUN1.SGM 31AUN1 60220 Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Notices Dated: August 28, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18836 Filed 8–30–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Lung Cellular, Molecular, and Immunobiology Study Section. Date: September 26–27, 2023. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Blvd., Gaithersburg, MD 20878. Contact Person: George M Barnas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892, 301–435– 0696, barnasg@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–22– 079: High-End Instrumentation (HEI) Grant Program. Date: September 26, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Krystyna H Szymczyk, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–4198, szymczykk@ csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Health Services: Quality and Effectiveness Study Section. Date: September 27–28, 2023. Time: 9:00 a.m. to 7:00 p.m. VerDate Sep<11>2014 18:04 Aug 30, 2023 Jkt 259001 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Angela D Thrasher, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301) 480–6894, thrasherad@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Pathophysiological Basis of Mental Disorders and Addictions Study Section. Date: September 27–28, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Boris P. Sokolov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–408– 9115, bsokolov@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Developmental Brain Disorders Study Section. Date: September 27–29, 2023. Time: 9:30 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Pat Manos, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, (301) 408– 9866, manospa@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Maximizing Investigators’ Research Award— F Study Section. Date: September 27–28, 2023. Time: 10:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Brian Paul Chadwick, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3586, chadwickbp@ csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 28, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18837 Filed 8–30–23; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Council of Councils, September 07, 2023, Partially Closed Meeting that was published in the Federal Register on August 08, 2023, 88 FR 53504. The publication is being amended to change the open session end time ‘‘3:15 p.m.’’ to ‘‘3:00 p.m.’’. In the amended portion of the notice, the open session end time of the Council of Councils meeting was listed in error. The meeting is partially closed to the public. Dated: August 25, 2023. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18880 Filed 8–30–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of K99/R00 Applications. Date: October 24–25, 2023. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Tracy Koretsky, Ph.D., Scientific Review Officer, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN12F, Bethesda, Maryland E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 88, Number 168 (Thursday, August 31, 2023)]
[Notices]
[Pages 60219-60220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18836]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK SEP High Risk 
Multi-Center Clinical Study Cooperative Agreement U01.
    Date: September 28, 2023.
    Time: 12:00 p.m. to 1:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review 
Officer, NIDDK/Scientific Review Branch, National Institutes of 
Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-
402-6711, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 60220]]


    Dated: August 28, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-18836 Filed 8-30-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.